SCHEMBL23844741

SCHEMBL23844741

CCCCCCC(CCCCC)Cc1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.43
TSHR P16473 2/20 0.43
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
CYP2C19 P33261 1/20 0.43
HDAC1 Q13547 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
RAB9A P51151 1/20 0.39
LMNA P02545 1/20 0.38
PRSS1 P07477 1/20 0.37
PRSS2 P07478 1/20 0.37
PRSS3 P35030 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CSNK1E P49674 1/20 0.36
MEN1 O00255 1/20 0.36
GAPDH P04406 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28193222 1.00 L3MBTL1 (0.43) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL16863665 1.00 L3MBTL1 (0.43) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL28501284 1.00 L3MBTL1 (0.43) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL19526473 1.00 L3MBTL1 (0.43) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL2710505 1.00 L3MBTL1 (0.43) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL159871 0.98 TSHR (0.46) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL18400718 0.97 L3MBTL1 (0.42) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL27986203 0.93 TSHR (0.48) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL23688797 0.93 TSHR (0.48) L3MBTL1TSHRGLAHTTCYP2C19
SCHEMBL21608630 0.93 TSHR (0.49) L3MBTL1TSHRGLAHTTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292300-A1 DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292300-A1 DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS TLR9, TLR7, TLR8 L3MBTL1 2346/4885TSHR 633/4885GLA 4660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.